Home
News
Screeners
Insights
Adeshwar Meditex
16.
30
0.00
(0.00%)
Market Cap
₹23.50 Cr
PE Ratio
33.09
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
+1.88%
6M
-22.38%
1Y
-9.44%
5Y
-35.19%
View Company Insights
Latest news about Adeshwar Meditex
Adeshwar Meditex accepts Satish Chudekar's resignation
8 days ago
Adeshwar Meditex Limited accepted the resignation of Satish Ramchandra Chudekar as Non-Executive Non-Independent Director effective August 3, 2026. Citing personal commitments, Chudekar stepped down from the Board and its Nomination & Remuneration Committee. The company confirmed no other material reasons for the exit.
Adeshwar Meditex corrects RPT figures reported to BSE
May 22, 2026
Adeshwar Meditex FY26 net profit at Rs 126.49 lakh
May 21, 2026
Adeshwar Meditex Reappoints M/s. Basude Makote & Saini as Internal Auditors for FY 2025-26 to 2027-28
May 14, 2026
Adeshwar Meditex Limited Files SEBI Compliance Disclosure for Quarter Ended March 31, 2026
Apr 08, 2026
More news about Adeshwar Meditex
07
Apr 26
Adeshwar Meditex Limited Files Annual SEBI Disclosure Under Takeover Regulations for FY26
Adeshwar Meditex Limited submitted its annual SEBI disclosure for FY26, confirming no share encumbrance by promoters during the year. Promoters Krishnojirao Nagaraja Rao and Abhinandan Nagaraja Rao hold 40,12,000 and 43,11,332 shares respectively as of March 31, 2026. The disclosure was filed with BSE under Regulation 31(4) of SEBI takeover regulations, ensuring compliance with substantial shareholding requirements.
20
Dec 25
Adeshwar Meditex Appoints New Independent Director and Reconstitutes Committees
Adeshwar Meditex Limited has made significant governance changes by appointing Mr. Raghupathy Bhat, a seasoned professional with 40+ years of experience, as Additional Non-Executive Independent Director. The company has also reconstituted its Audit, Nomination and Remuneration, and Stakeholder Relationship Committees to reflect the new board composition, with an EGM scheduled for January 20, 2025, to seek shareholder approval.
31
Oct 25
Adeshwar Meditex Reports Passing of Independent Director, Mr. Benegal Parameshwara Udpa
Adeshwar Meditex Limited reported the death of Mr. Benegal Parameshwara Udpa, a Non-Executive Independent Director, on October 22, 2025. The company was informed on October 28, 2025, and immediately notified BSE. A clarification was provided to BSE on October 30, 2025, explaining the delay in announcement due to late communication from the director's family.
28
Oct 25
Adeshwar Meditex Mourns the Loss of Independent Director Benegal Parameshwara Udpa
Adeshwar Meditex Limited has reported the demise of Mr. Benegal Parameshwara Udpa, a Non-Executive Independent Director, on October 22, 2025. Mr. Udpa, who joined the board on June 30, 2023, was recognized for his significant contributions, including active participation in meetings, valuable guidance, and dedicated service. The company's board expressed deep appreciation for his work and conveyed condolences to his family, acknowledging the loss as irreparable.
25
Oct 25
Adeshwar Meditex Appoints New Statutory Auditor Following Resignation
Adeshwar Meditex Limited's Board of Directors has approved the appointment of M/s. Rajesh H. Gupta & Co. as the new statutory auditor, effective October 24, 2025. This decision follows the resignation of the previous auditor, M/s. J N Gupta & Co. LLP. The new auditor's term will last until the conclusion of the next Annual General Meeting, subject to shareholder approval. M/s. Rajesh H. Gupta & Co. is a professionally managed firm with expertise in various financial services. The appointment complies with SEBI regulations, and the company has informed the BSE Limited of this change.
Adeshwar Meditex
16.
30
0.0
(0.0%)
1 Year Returns:
-9.44%
Industry Peers
Syngene International
408.65
(+
0.
34
%)
Indegene
565.40
(-
0.
39
%)
Suven Life Sciences
330.55
(-
2.
92
%)
Vimta Labs
627.15
(-
2.
50
%)
TAKE
23.54
(+
1.
25
%)
Jeevan Scientific Technology
78.52
(0.0%)
Bilcare
64.62
(-
0.
46
%)
Adeshwar Meditex
16.30
(0.0%)
Vanta Bioscience
20.67
(0.0%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar